The European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) is a European medical association focused on the gastrointestinal health of children1
The ESPGHAN IBD Porto group is a group of experts who generate collaborative international research on the diagnosis and management of IBD in children2
The ESPGHAN IBD Porto group released an updated position statement in 2019 that supports the use of INFLECTRA® (CT-P13*/infliximab) in appropriate paediatric patients with IBD3
Please refer to the INFLECTRA® Summary of Product Characteristics for full prescribing information
Pfizer has a range of resources available to support you and your patients
Legal Category: S1A
Further information is available upon request
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
I accept and agree to the terms of use.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023